Show simple item record

dc.contributor.authorVora, Ajay J
dc.contributor.authorMitchell, Christopher D
dc.contributor.authorLennard, Lynne
dc.contributor.authorEden, Tim O B
dc.contributor.authorKinsey, Sally E
dc.contributor.authorLilleyman, John S
dc.contributor.authorRichards, Susan M
dc.date.accessioned2009-07-06T15:48:17Z
dc.date.available2009-07-06T15:48:17Z
dc.date.issued2006-10
dc.identifier.citationToxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. 2006, 368:1339-1348 Lanceten
dc.identifier.issn01406736
dc.identifier.issn1474547X
dc.identifier.doi10.1016/S0140-6736(06)69558-5
dc.identifier.urihttp://hdl.handle.net/10541/72640
dc.language.isonullen
dc.subjectLymphoblastic Leukaemiaen
dc.subjectChilden
dc.subjectRandomized Trialen
dc.titleToxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial
dc.typeArticleen
dc.contributor.departmentDepartment of Paediatric Haematology, Sheffield Children's Hospital, Sheffield S10 2TH, UKen
dc.identifier.journalThe Lanceten


Files in this item

This item appears in the following Collection(s)

Show simple item record